Encouraging results, even if it was low season We raise our EBITA estimates 2-3% on '25e-'27e Svensk...
Alzecure har på senare tid stärkt profilen för bolagets ledande projekt, ACD856, genom att visa data...
Redeye's provides its initial take on Xbrane's Q1 report which confirmed a stronger than anticipated...
Redeye provides a brief comment on Paxman’s announcement to complete the offer for Dignitana.
Redeye comments on I-Tech’s Q1 figures that beat our estimates across the board, delivering growth o...
Redeye comments on Transtema’s Q1 report, showing strong organic growth in Sweden but a relatively s...
Sales +9% and EBIT +14% vs. ABGSCe Expect cons. to raise '25e-'27e sales by ~3-4% USD/SEK movements ...
Redeye noted InfraCom's robust profitability, surpassing its EBITDA estimate by 21%.
Redeye comments on Truecaller’s Q1 2025 report, which was somewhat softer than expected.
Redeye noted that BeammWave's Q1 2025 report significantly exceeded expectations, primarily due to r...
Redeye updates on G5 Entertainment post Q1-result which saw lower revenue than expected.
Redeye comments on BrightBid’s Q1 report, with numbers aligning with the preliminary figures.
Redeye comments on the announcement of SEK13.6m loan, a directed issue of warrants and a SEK10.
Investors House's Q1 report was solid, with Real Estate posting slightly better results than we esti...
Redeye strengthens its positive view of Avensia following a strong Q1 report, showing high growth an...
